NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 195 filers reported holding NEKTAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $316,000 | -78.9% | 6,562 | -53.4% | 0.00% | -66.7% |
Q1 2018 | $1,496,000 | +78.7% | 14,077 | +0.4% | 0.00% | +200.0% |
Q4 2017 | $837,000 | +381.0% | 14,016 | +90.9% | 0.00% | – |
Q3 2017 | $174,000 | +22.5% | 7,341 | 0.0% | 0.00% | – |
Q2 2017 | $142,000 | -58.5% | 7,341 | -50.0% | 0.00% | – |
Q1 2017 | $342,000 | +280.0% | 14,682 | +100.0% | 0.00% | – |
Q4 2016 | $90,000 | -28.6% | 7,341 | 0.0% | 0.00% | – |
Q3 2016 | $126,000 | +21.2% | 7,341 | 0.0% | 0.00% | – |
Q2 2016 | $104,000 | +4.0% | 7,341 | 0.0% | 0.00% | – |
Q1 2016 | $100,000 | -19.4% | 7,341 | 0.0% | 0.00% | – |
Q4 2015 | $124,000 | +55.0% | 7,341 | 0.0% | 0.00% | – |
Q3 2015 | $80,000 | -12.1% | 7,341 | 0.0% | 0.00% | – |
Q2 2015 | $91,000 | +12.3% | 7,341 | 0.0% | 0.00% | – |
Q1 2015 | $81,000 | -28.9% | 7,341 | 0.0% | 0.00% | – |
Q4 2014 | $114,000 | -100.0% | 7,341 | -70.4% | 0.00% | – |
Q3 2014 | $299,047,000 | +217.8% | 24,776 | +237.5% | 0.00% | – |
Q2 2014 | $94,112,000 | +5.8% | 7,341 | 0.0% | 0.00% | – |
Q1 2014 | $88,973,000 | +6.8% | 7,341 | 0.0% | 0.00% | – |
Q4 2013 | $83,320,000 | +8.7% | 7,341 | 0.0% | 0.00% | – |
Q3 2013 | $76,677,000 | – | 7,341 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
CM Management, LLC | 35,000 | $595,000 | 0.55% |
OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |